[go: up one dir, main page]

GB9504235D0 - Pharmaceutical compositon - Google Patents

Pharmaceutical compositon

Info

Publication number
GB9504235D0
GB9504235D0 GBGB9504235.4A GB9504235A GB9504235D0 GB 9504235 D0 GB9504235 D0 GB 9504235D0 GB 9504235 A GB9504235 A GB 9504235A GB 9504235 D0 GB9504235 D0 GB 9504235D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositon
compositon
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9504235.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent UK Swindon Encaps Ltd
Original Assignee
Catalent UK Swindon Encaps Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent UK Swindon Encaps Ltd filed Critical Catalent UK Swindon Encaps Ltd
Priority to GBGB9504235.4A priority Critical patent/GB9504235D0/en
Publication of GB9504235D0 publication Critical patent/GB9504235D0/en
Priority to GBGB9517063.5A priority patent/GB9517063D0/en
Priority to PCT/GB1996/000484 priority patent/WO1996026720A1/en
Priority to AT96904929T priority patent/ATE241346T1/en
Priority to PT96904929T priority patent/PT814789E/en
Priority to TR97/00878T priority patent/TR199700878T1/en
Priority to HU9801227A priority patent/HU228852B1/en
Priority to KR1019970706111A priority patent/KR100418210B1/en
Priority to EE9700187A priority patent/EE04039B1/en
Priority to SI9630617T priority patent/SI0814789T2/en
Priority to CZ0270597A priority patent/CZ297382B6/en
Priority to GEAP19963934A priority patent/GEP20012374B/en
Priority to SK1158-97A priority patent/SK284383B6/en
Priority to DK96904929T priority patent/DK0814789T4/en
Priority to RO97-01781A priority patent/RO126460A2/en
Priority to CNB961923032A priority patent/CN1171586C/en
Priority to BR9607057A priority patent/BR9607057A/en
Priority to PL96322046A priority patent/PL183266B1/en
Priority to EP96904929A priority patent/EP0814789B2/en
Priority to US08/894,764 priority patent/US20010021722A1/en
Priority to NZ329471A priority patent/NZ329471A/en
Priority to CA002214026A priority patent/CA2214026C/en
Priority to ES96904929T priority patent/ES2199283T5/en
Priority to JP52610896A priority patent/JP3273141B2/en
Priority to DE69628415T priority patent/DE69628415T3/en
Priority to NZ302723A priority patent/NZ302723A/en
Priority to AU48846/96A priority patent/AU702161B2/en
Priority to ZA961735A priority patent/ZA961735B/en
Priority to IS4553A priority patent/IS2789B/en
Priority to NO19974010A priority patent/NO316804B1/en
Priority to MX9706647A priority patent/MX9706647A/en
Priority to BG101937A priority patent/BG63862B1/en
Priority to US10/610,613 priority patent/US20040091525A1/en
Priority to US10/957,947 priority patent/US20050106241A1/en
Priority to US11/850,141 priority patent/US20080187573A1/en
Priority to US12/782,584 priority patent/US9820937B2/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9504235.4A 1995-02-03 1995-03-02 Pharmaceutical compositon Pending GB9504235D0 (en)

Priority Applications (36)

Application Number Priority Date Filing Date Title
GBGB9504235.4A GB9504235D0 (en) 1995-03-02 1995-03-02 Pharmaceutical compositon
GBGB9517063.5A GB9517063D0 (en) 1995-03-02 1995-08-18 Pharmaceutical composition
AU48846/96A AU702161B2 (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase B inhibitors
BR9607057A BR9607057A (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
US08/894,764 US20010021722A1 (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
PT96904929T PT814789E (en) 1995-03-02 1996-03-01 PHARMACEUTICAL COMPOSITIONS UNDER COMPOSITION OF MONOAMINE-OXIDASE B INHIBITORS
TR97/00878T TR199700878T1 (en) 1995-03-02 1996-03-01 Pharmacological compositions containing inhibitors of monamine oxidase B.
HU9801227A HU228852B1 (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
KR1019970706111A KR100418210B1 (en) 1995-03-02 1996-03-01 A pharmaceutical composition comprising a monoamine oxide B inhibitor
EE9700187A EE04039B1 (en) 1995-03-02 1996-03-01 Pharmaceutical composition for oral administration, process for its preparation and use
SI9630617T SI0814789T2 (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
CZ0270597A CZ297382B6 (en) 1995-03-02 1996-03-01 Rapidly dispersing oral solid dosage form of pharmaceutical for the treatment of Parkinson's disease
GEAP19963934A GEP20012374B (en) 1995-03-02 1996-03-01 Pharmaceutical Compositions Comprising Monoamine Oxidase B Inhibitors, Method for Obtaining the Same and Use
SK1158-97A SK284383B6 (en) 1995-03-02 1996-03-01 Oral pharmaceutical composition comprising monoamine oxidase B inhibitors and its use
DK96904929T DK0814789T4 (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase B inhibitors
RO97-01781A RO126460A2 (en) 1995-03-02 1996-03-01 Pharmaceutical compositions containing monoamine oxidase b inhibitors
CNB961923032A CN1171586C (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase B inhibitors
PCT/GB1996/000484 WO1996026720A1 (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
PL96322046A PL183266B1 (en) 1995-03-02 1996-03-01 Pharmaceutic compositions containing inhibitors of monoamino oxidase b
EP96904929A EP0814789B2 (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
AT96904929T ATE241346T1 (en) 1995-03-02 1996-03-01 MEDICINAL PRODUCTS CONTAINING MONOAMINOOXIDASE-B INHIBITORS
NZ329471A NZ329471A (en) 1995-03-02 1996-03-01 Use of monoamide oxidase b inhibitors to treat parkinson's disease
CA002214026A CA2214026C (en) 1995-03-02 1996-03-01 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
ES96904929T ES2199283T5 (en) 1995-03-02 1996-03-01 PHARMACEUTICAL COMPOSITIONS INCLUDING INHIBITORS OF MONOAMINE OXIDASA B.
JP52610896A JP3273141B2 (en) 1995-03-02 1996-03-01 Pharmaceutical composition comprising monoamine oxidase B inhibitor
DE69628415T DE69628415T3 (en) 1995-03-02 1996-03-01 DRUGS CONTAINING MONOAMINE OXIDASE B HEMMER
NZ302723A NZ302723A (en) 1995-03-02 1996-03-01 Composition comprising monoamine oxidase b inhibitor and a carrier formulated for pre-gastric absorption of the monoamine oxidase b inhibitor
ZA961735A ZA961735B (en) 1995-03-02 1996-03-04 Pharmaceutical composition
IS4553A IS2789B (en) 1995-03-02 1997-08-27 Medicinal preparations containing monoamine oxidase B inhibitors
NO19974010A NO316804B1 (en) 1995-03-02 1997-09-01 Pharmaceutical compositions comprising monoamine oxidase B inhibitors, process for their preparation and use of the same
MX9706647A MX9706647A (en) 1995-03-02 1997-09-02 Pharmaceutical compositions comprising monoamine oxidase b inhibitors.
BG101937A BG63862B1 (en) 1995-03-02 1997-10-01 Paharmaceutical compositions comprising monoamine oxidase b inhibitors
US10/610,613 US20040091525A1 (en) 1995-03-02 2003-07-01 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitor component
US10/957,947 US20050106241A1 (en) 1995-02-03 2004-10-04 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitors
US11/850,141 US20080187573A1 (en) 1995-03-02 2007-09-05 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase b inhibitor component
US12/782,584 US9820937B2 (en) 1995-03-02 2010-05-18 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504235.4A GB9504235D0 (en) 1995-03-02 1995-03-02 Pharmaceutical compositon

Publications (1)

Publication Number Publication Date
GB9504235D0 true GB9504235D0 (en) 1995-04-19

Family

ID=10770547

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9504235.4A Pending GB9504235D0 (en) 1995-02-03 1995-03-02 Pharmaceutical compositon
GBGB9517063.5A Pending GB9517063D0 (en) 1995-02-03 1995-08-18 Pharmaceutical composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
GBGB9517063.5A Pending GB9517063D0 (en) 1995-02-03 1995-08-18 Pharmaceutical composition

Country Status (4)

Country Link
KR (1) KR100418210B1 (en)
GB (2) GB9504235D0 (en)
RO (1) RO126460A2 (en)
ZA (1) ZA961735B (en)

Also Published As

Publication number Publication date
ZA961735B (en) 1996-11-18
KR100418210B1 (en) 2004-05-31
RO126460A2 (en) 2011-07-29
GB9517063D0 (en) 1995-10-25
KR19980702704A (en) 1998-08-05

Similar Documents

Publication Publication Date Title
HU9601698D0 (en) Pharmaceutical composition
ZA96527B (en) Novel pharmaceutical combination
GB9722600D0 (en) Pharmaceutical compositon
ZA962214B (en) Pharmaceutical composition
GB9519667D0 (en) Pharmaceutical composition
EG24294A (en) Pharmaceutical compositions
ZA963590B (en) Pharmaceutical composition
ZA9610426B (en) Pharmaceutical composition
ZA961051B (en) Pharmaceutical composition
ZA964193B (en) Pharmaceutical composition
HU9603498D0 (en) Pharmaceutical compounds
ZA968616B (en) Pharmaceutical composition
ZA963591B (en) Pharmaceutical composition
GB9504235D0 (en) Pharmaceutical compositon
ZA95736B (en) Pharmaceutical composition
GB9526437D0 (en) Pharmaceutical compounds
GB9522132D0 (en) Pharmaceutical compounds
GB9517867D0 (en) Pharmaceutical compounds
GB9517866D0 (en) Pharmaceutical compounds
GB9517865D0 (en) Pharmaceutical compounds
GB9506273D0 (en) Pharmaceutical compounds
GB9502811D0 (en) Pharmaceutical compounds
GB9511166D0 (en) Pharmaceutical compounds
GB9526439D0 (en) Pharmaceutical compound
GB9521970D0 (en) Novel pharmaceutical